Skip to Content
Developmental Therapeutics Program (DTP)
Last Updated: 04/08/15

Other Programs of Interest

  • NCI Experimental Therapeutics Program (NExT)
    Application Receipt Dates: November 15, February 15, May 15 and August 15
  • Chemical Biology Consorium (CBC): A new program in DCTD designed to accelerate discovery and development of effective first-in-class targeted therapies. Check the DCTD web site for current opportunities.
  • Quick Trials: A funding mechanism through the Cancer Therapy Evaluation Program to support pilot clinical trials exploring individual agents or combinations focused on specific molecular targets.

Helpful Related Links

About the Branch Chief

Dr. Sundar Venkatachalam Dr. Sundar Venkatachalam serves as the chief of PTGB. Sundar earned his Ph.D. in Biochemistry from the Ohio State University, where he studied the molecular mechanisms of DNA damage and repair responses induced by polycyclic aromatic hydrocarbons. As a postdoctoral fellow at the Baylor College of Medicine, he analyzed the role of the p53 haploinsufficiency in tumor susceptibility and aging using genetically engineered mouse models. More…